Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Osteochondroma 1 Exostoses, Multiple Hereditary 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Osteochondroma × Palovarotene × Clear all

NCT03442985 2022-08-01

MO-Ped

Ipsen

Phase 2 Terminated

193 enrolled 20 charts

Exostoses, Multiple Hereditary, Osteochondroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡